Viridian Therapeutics Inc Asset Turnover Ratio (VRDN), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Viridian Therapeutics Inc   (NASDAQ: VRDN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Viridian Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Viridian Therapeutics Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.1 in the first quarter (Mar 31 2026)

Within sector 28 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2026, to 2921, from total ranking in the fourth quarter 2025 at 2922.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VRDN Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change 6.52 % 16.86 % -1.56 % 4.86 % 51.12 %
Y / Y Revenue Change 95.83 % 40.7 % 97913.89 % 0 % 0 %
Asset Turnover Ratio (TTM) 0.1 0.1 0.1 0 0
VRDN's Total Ranking # 2921 # 2922 # 2957 # 3777 #
Seq. Asset Change -12.27 % 56.14 % -12.85 % -10.76 % -3.76 %
Seq. Revenue Change 16.53 % -99.83 % 97913.89 % 0 % -16.28 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 29
Healthcare Sector # 451
Overall Market # 2921

Asset Turnover Ratio Statistics
High Average Low
0.1 0.02 0
(Sep 30 2025)   (Mar 31 2025)




VRDN Company Profile • Back to VRDN Efficiency Comparisons • Compare VRDN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Keenova Therapeutics Plc  0.25 $ 1,413.000  Millions$ 5,720.150  Millions
Theravance Biopharma inc   0.24 $ 109.775  Millions$ 449.845  Millions
Revvity Inc  0.24 $ 2,902.407  Millions$ 12,166.686  Millions
Cryoport inc   0.24 $ 182.935  Millions$ 769.213  Millions
Enanta Pharmaceuticals Inc  0.24 $ 69.213  Millions$ 294.299  Millions
Verastem Inc   0.23 $ 49.585  Millions$ 211.842  Millions
Nuvation Bio Inc   0.23 $ 142.121  Millions$ 613.462  Millions
Arcus Biosciences Inc   0.23 $ 236.000  Millions$ 1,046.250  Millions
Precigen Inc   0.22 $ 31.595  Millions$ 141.823  Millions
Personalis Inc   0.22 $ 64.515  Millions$ 290.270  Millions
Nutriband Inc   0.22 $ 1.803  Millions$ 8.259  Millions
Marker Therapeutics inc   0.22 $ 3.949  Millions$ 18.252  Millions
Editas Medicine Inc   0.21 $ 38.693  Millions$ 187.051  Millions
Wave Life Sciences Ltd   0.21 $ 88.173  Millions$ 428.944  Millions
Pacific Biosciences Of California Inc   0.20 $ 159.992  Millions$ 798.769  Millions
Zymeworks Inc   0.20 $ 81.263  Millions$ 407.599  Millions
Ligand Pharmaceuticals Incorporated  0.20 $ 274.476  Millions$ 1,379.530  Millions
Arcturus Therapeutics Holdings Inc   0.20 $ 54.710  Millions$ 277.043  Millions
Beyond Air Inc   0.19 $ 6.065  Millions$ 31.132  Millions
Dariohealth Corp   0.19 $ 20.983  Millions$ 109.852  Millions
Xoma Royalty Corporation  0.19 $ 48.555  Millions$ 257.791  Millions
Coya Therapeutics Inc   0.19 $ 7.939  Millions$ 42.179  Millions
Biocorrx Inc   0.19 $ 0.877  Millions$ 4.672  Millions
Moderna Inc   0.19 $ 2,225.000  Millions$ 11,992.750  Millions
Regenxbio Inc   0.18 $ 87.822  Millions$ 475.289  Millions
Cannapharmarx Inc   0.18 $ 1.654  Millions$ 9.172  Millions
Alpha Cognition Inc.  0.18 $ 10.825  Millions$ 60.101  Millions
4d Molecular Therapeutics Inc   0.18 $ 88.242  Millions$ 494.309  Millions
60 Degrees Pharmaceuticals Inc   0.17 $ 1.004  Millions$ 5.750  Millions
Inspiremd Inc   0.17 $ 10.044  Millions$ 59.422  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.